Learn more

CYTOTHERAPEUTICS INC

Overview
  • Total Patents
    161
About

CYTOTHERAPEUTICS INC has a total of 161 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ANGIOCRINE BIOSCIENCE INC, THE CHEMO-SERO-THERAPEUTIC RES INST and NEUROTROPHINCELL PTY LTD.

Patent filings per year

Chart showing CYTOTHERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hammang Joseph P 74
#2 Aebischer Patrick 54
#3 Gentile Frank T 46
#4 Holland Laura M 46
#5 Winn Shelley R 46
#6 Doherty Edward J 35
#7 Cain Brian M 32
#8 Schinstine Malcolm 30
#9 Shoichet Molly S 29
#10 Dionne Keith E 20

Latest patents

Publication Filing date Title
AU1005400A Pain cell line
WO9952586A1 Tether anchor
AU3641299A Tether anchor
AU8424098A Growth control for cells encapsulated within bioartificial organs
MX9709828A Cell line producing analgesic compounds for treating pain.
MX9709709A Apparatus and method for storage and transportation of bioartificial organs.
US5968829A Human CNS neural stem cells
AU3823697A Biocompatible devices with foam scaffolds
WO9744057A1 System and method for delivery of cytokines using encapsulated cytokine-secreting cells
US5844077A Use of conantokins for producing analgesia or for neuroprotection
AU2674097A Method and device for delivery of apoptosis-inducing molecules
WO9712635A1 Method for treating amyotrophic lateral sclerosis
ZA9604880B Pain cell line
US6027721A Device and method for encapsulated gene therapy
US5904144A Method for treating ophthalmic diseases
US5837234A Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
US5681740A Apparatus and method for storage and transporation of bioartificial organs
US5908623A Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5773286A Inner supported biocompatible cell capsules
US5858747A Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers